Anti-Retropulsion Devices Market Report 2025

This Anti-Retropulsion Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The anti-retropulsion devices market size has grown strongly in recent years. It will grow from $2.4 billion in 2024 to $2.58 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to the increasing prevalence of kidney stones, demand for minimally invasive procedures, advancements in healthcare infrastructure globally, regulatory approvals and standards evolution, and growth in the aging population.

The anti-retropulsion devices market size is expected to see strong growth in the next few years. It will grow to $3.43 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the expansion of healthcare infrastructure in emerging markets, regulatory support, expansion of healthcare facilities, growing awareness and education, and a and a shift towards outpatient procedures. Major trends in the forecast period include technological advancements, innovations in device design and materials, robotics and automation, biodegradable devices, and patient-specific solutions.

The increasing prevalence of chronic kidney disease is anticipated to drive the growth of the anti-retropulsion device market in the future. Chronic kidney disease encompasses a wide range of conditions impacting kidney structure and function. Factors such as unhealthy diets, sedentary lifestyles, obesity, smoking, and excessive alcohol consumption contribute to the rise in kidney-related issues. Anti-retropulsion devices are utilized in urological procedures to improve treatment effectiveness by preventing kidney stone fragments from migrating back towards the kidney during procedures. For instance, in June 2024, data from the Australian Institute of Health and Welfare, an Australian government agency, indicated a slight year-on-year rise in CKD mortality rates in both 2021 and 2022, with increases of 4.2% and 6.2%, respectively. Thus, the growing prevalence of chronic kidney disease is expected to boost the anti-retropulsion device market.

Key players in the anti-retropulsion device market are focusing on enhancing design and innovating user-centric solutions, such as vacuum-assisted kidney stone removal devices, to improve patient outcomes and reduce procedural times. These medical tools use suction to capture and remove kidney stones from the urinary tract, enhancing the efficiency of urological procedures. For instance, in March 2024, Calyxo, Inc., a US-based medical device company, launched the CVAC System, designed for efficient kidney stone removal using irrigation and vacuum aspiration during and after laser lithotripsy, aiming for stone-free outcomes.

In June 2024, The Medical City, a hospital based in the Philippines, acquired the Lumenis Moses 2 machine for an undisclosed amount. This acquisition aims to enhance The Medical City’s standing as a leader in urological services by offering advanced, minimally invasive treatment options for kidney stones and benign prostate enlargement (BPH). The new equipment is expected to improve patient outcomes by providing greater precision, efficiency, and shorter recovery times. Lumenis Ltd., an Israel-based company, specializes in the production of anti-retropulsion devices.

Major companies operating in the anti-retropulsion devices market are Johnson & Johnson, Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, STERIS Corporation, C.R. Bard Inc., Coloplast A/S, Teleflex Incorporated, Cook Medical Incorporated, Karl Storz SE & Co. KG, Merit Medical Systems Inc., Ambu A/S, Applied Medical Resources Corporation, Gyrus ACMI Inc., Dornier MedTech GmbH, Accordion Medical LLC, Cogentix Medical Inc., Biolitec AG, ROCAMED SAM, blueneem Medical Devices Pvt. Ltd., Elmed Medical Systems Inc., Endotherapeutics Pty Ltd, Maxer Endoscopy GmbH.

North America was the largest region in the anti-retropulsion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-retropulsion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anti-retropulsion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Anti-retropulsion devices are instruments utilized in medical procedures, particularly in urology, to prevent kidney stones or fragments from moving back up the ureter towards the kidney during lithotripsy or other stone removal procedures. These tools stabilize stones or fragments within the urinary tract, aiding their passage or extraction without causing obstruction or complications.

The primary types of anti-retropulsion devices include basket-type, balloon-type, and other specialized variants. Basket-type devices are specifically designed for urological procedures to capture and remove kidney stones or fragments. These devices find applications in ureteroscopy, lithotripsy, and are used in settings such as hospitals and ambulatory surgical centers.

The anti-retropulsion devices market research report is one of a series of new reports that provides anti-retropulsion devices market statistics, including anti-retropulsion devices industry global market size, regional shares, competitors with an anti-retropulsion devices market share, detailed anti-retropulsion devices market segments, market trends and opportunities, and any further data you may need to thrive in the anti-retropulsion devices industry. This anti-retropulsion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-retropulsion devices market consists of sales of retrieval baskets, ureteral access sheaths, and tipless nitinol stone baskets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.